Clinical Trial Update: Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy [NA]

View source ↗

Summary

Completed clinical trial evaluating whether RAAS blockade influences the incidence of radiographic contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• RAAS blockade

Snippet

Sponsor: Soroka University Medical Center | Conditions: Radiographic Contrast Agent Nephropathy | NA | Status: COMPLETED